Crystallizing new approaches for antimicrobial drug discovery

Biochemical Pharmacology

Volumn 71, Issue 7, 2006, Pages 1048-1056

  Schmid, Molly B ^a  

^a KECK GRADUATE INSTITUTE   (United States)

Author keywords

Antibacterials; Antibiotics; Antimicrobial drug discovery; Structural genomics; Structure guided drug discovery

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; ENZYME INHIBITOR; TRANSFERASE INHIBITOR;

DRUG SCREENING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FATTY ACID SYNTHESIS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROKARYOTE; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STRUCTURAL GENOMICS;

EID: 33644503872     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.12.024     Document Type: Article

References (79)

1. C.J. Thomson, E. Power, H. Ruebsamen-Waigmann, and H. Labischinski Antibacterial research and development in the 21st century - an industry perspective of the challenges Curr Opin Microbiol 7 2004 445 450
2. S.J. Projan, and D.M. Shlaes Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect 10 Suppl. 4 2004 18 22
3. M.B. Schmid Seeing is believing: the impact of structural genomics on antimicrobial drug discovery Nat Rev Microbiol 2 2004 739 746
4. K.M. Overbye, and J.F. Barrett Antibiotics: where did we go wrong? Drug Discov Today 10 2005 45 52
5. L. Miesel, J. Greene, and T.A. Black Genetic strategies for antibacterial drug discovery Nat Rev Genet 4 2003 442 456
6. W.H. Miller, M.A. Seefeld, K.A. Newlander, I.N. Uzinskas, W.J. Burgess, and D.A. Heerding Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI) J Med Chem 45 2002 3246 3256
7. M.A. Seefeld, W.H. Miller, K.A. Newlander, W.J. Burgess, W.E. DeWolf Jr., and P.A. Elkins Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK J Med Chem 46 2003 1627 1635
8. R.F. Service Structural genomics. Tapping DNA for structures produces a trickle. Science 298 2002 948 950
9. Konforti B. PSI-phase 1 and beyond. Nat Struct Mol Biol 2004;11:201.
10. C.J. Oldfield, E.L. Ulrich, Y. Cheng, A.K. Dunker, and J.L. Markley Addressing the intrinsic disorder bottleneck in structural proteomics Proteins 59 2005 444 453
11. C.S. Goh, N. Lan, S.M. Douglas, B. Wu, N. Echols, and A. Smith Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis J Mol Biol 336 2004 115 130
12. S.C. Makrides Strategies for achieving high-level expression of genes in Escherichia coli Microbiol Rev 60 1996 512 538
13. N. Siew, and D. Fischer Analysis of singleton ORFans in fully sequenced microbial genomes Proteins 53 2003 241 251
14. T.E. Benson, D.J. Filman, C.T. Walsh, and J.M. Hogle An enzyme-substrate complex involved in bacterial cell wall biosynthesis Nat Struct Biol 2 1995 644 653
15. S.L. Laporte, C.M. Forsyth, B.C. Cunningham, L.J. Miercke, D. Akhavan, and R.M. Stroud De novo design of an IL-4 antagonist and its structure at 1.9 A Proc Natl Acad Sci USA 102 2005 1889 1894
16. B.T. Wimberly, D.E. Brodersen, W.M. Clemons Jr., R.J. Morgan-Warren, A.P. Carter, and C. Vonrhein Structure of the 30S ribosomal subunit Nature 407 2000 327 339
17. N. Ban, P. Nissen, J. Hansen, P.B. Moore, and T.A. Steitz The complete atomic structure of the large ribosomal subunit at 2.4 A resolution Science 289 2000 905 920
18. C. Venclovas, A. Zemla, K. Fidelis, and J. Moult Assessment of progress over the CASP experiments Proteins 53 Suppl. 6 2003 585 595
19. J. Moult A decade of CASP: progress, bottlenecks and prognosis in protein structure prediction Curr Opin Struct Biol 15 2005 285 289
20. R. Wang, X. Fang, Y. Lu, C.Y. Yang, and S. Wang The PDBbind database: methodologies and updates J Med Chem 48 2005 4111 4119
21. R.D. Smith, L. Hu, J.A. Falkner, M.L. Benson, J.P. Nerothin, and H.A. Carlson Exploring protein-ligand recognition with Binding MOAD J Mol Graph Model 2005
22. L. Hu, M.L. Benson, R.D. Smith, M.G. Lerner, and H.A. Carlson Binding MOAD (Mother Of All Databases) Proteins 60 2005 333 340
23. S.P. Williams, L.F. Kuyper, and K.H. Pearce Recent applications of protein crystallography and structure-guided drug design Curr Opin Chem Biol 9 2005 371 380
24. G. Schneider, and U. Fechner Computer-based de novo design of drug-like molecules Nat Rev Drug Discov 4 2005 649 663
25. I. Tickle, A. Sharff, M. Vinkovic, J. Yon, and H. Jhoti High-throughput protein crystallography and drug discovery Chem Soc Rev 33 2004 558 565
26. P.J. Hajduk, J.R. Huth, and S.W. Fesik Druggability indices for protein targets derived from NMR-based screening data J Med Chem 48 2005 2518 2525
27. C. Lipinski, and A. Hopkins Navigating chemical space for biology and medicine Nature 432 2004 855 861
28. Z. Nie, C. Perretta, J. Lu, Y. Su, S. Margosiak, and K.S. Gajiwala Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents J Med Chem 48 2005 1596 1609
29. N. Campobasso, M. Patel, I.E. Wilding, H. Kallender, M. Rosenberg, and M.N. Gwynn Staphylococcus aureus 3-hydroxy-3-methylglutaryl-CoA synthase: crystal structure and mechanism J Biol Chem 279 2004 44883 44888
30. D.A. Whittington, K.M. Rusche, H. Shin, C.A. Fierke, and D.W. Christianson Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis Proc Natl Acad Sci USA 100 2003 8146 8150
31. B.E. Coggins, A.L. McClerren, L. Jiang, X. Li, J. Rudolph, and O. Hindsgaul Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design Biochemistry 44 2005 1114 1126
32. B.E. Coggins, X. Li, A.L. McClerren, O. Hindsgaul, C.R. Raetz, and P. Zhou Structure of the LpxC deacetylase with a bound substrate-analog inhibitor Nat Struct Biol 10 2003 645 651
33. R.A. Daines, I. Pendrak, K. Sham, G.S. Van Aller, A.K. Konstantinidis, and J.T. Lonsdale First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modelling J Med Chem 46 2003 5 8
34. D.J. Payne The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents Drug News Perspect 17 2004 187 194
35. D. Tu, G. Blaha, P.B. Moore, and T.A. Steitz Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance Cell 121 2005 257 270
36. J.A. Sutcliffe Improving on nature: antibiotics that target the ribosome Curr Opin Microbiol 2005
37. X. Qiu, A.E. Choudhry, C.A. Janson, M. Grooms, R.A. Daines, and J.T. Lonsdale Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus Protein Sci 14 2005 2087 2094
38. F. Musayev, S. Sachdeva, J.N. Scarsdale, K.A. Reynolds, and H.T. Wright Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A J Mol Biol 346 2005 1313 1321
39. K. Das, A.D. Clark Jr., P.J. Lewi, J. Heeres, M.R. De Jonge, and L.M. Koymans Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants J Med Chem 47 2004 2550 2560
40. H. Ohtaka, and E. Freire Adaptive inhibitors of the HIV-1 protease Prog Biophys Mol Biol 88 2005 193 208
41. T. Skarzynski, A. Mistry, A. Wonacott, S.E. Hutchinson, V.A. Kelly, and K. Duncan Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin Structure 4 1996 1465 1474
42. S. Eschenburg, W. Kabsch, M.L. Healy, and E. Schonbrunn A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states J Biol Chem 278 2003 49215 49222
43. T. Skarzynski, D.H. Kim, W.J. Lees, C.T. Walsh, and K. Duncan Stereochemical course of enzymatic enolpyruvyl transfer and catalytic conformation of the active site revealed by the crystal structure of the fluorinated analogue of the reaction tetrahedral intermediate bound to the active site of the C115A mutant of MurA Biochemistry 37 1998 2572 2577
44. S. Eschenburg, M.A. Priestman, F.A. Abdul-Latif, C. Delachaume, F. Fassy, and E. Schonbrunn A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) J Biol Chem 280 2005 14070 14075
45. C. DeWeese-Scott, and J. Moult Molecular modeling of protein function regions Proteins 55 2004 942 961
46. L.L. Silver, and K.A. Bostian Discovery and development of new antibiotics: the problem of antibiotic resistance Antimicrob Agents Chemother 37 1993 377 383
47. X.Z. Li, and H. Nikaido Efflux-mediated drug resistance in bacteria Drugs 64 2004 159 204
48. E.W. Yu, G. McDermott, H.I. Zgurskaya, H. Nikaido, and D.E. Koshland Jr. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump Science 300 2003 976 980
49. R.C. Lemoine, T.W. Glinka, W.J. Watkins, A. Cho, J. Yang, and N. Iqbal Quinazolinone-based fungal efflux pump inhibitors. Part 1: discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp Bioorg Med Chem Lett 14 2004 5127 5131
50. T.E. Renau, R. Leger, L. Filonova, E.M. Flamme, M. Wang, and R. Yen Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Bioorg Med Chem Lett 13 2003 2755 2758
51. T.E. Renau, R. Leger, E.M. Flamme, J. Sangalang, M.W. She, and R. Yen Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin J Med Chem 42 1999 4928 4931
52. K.M. Kutterer, J.M. Davis, G. Singh, Y. Yang, W. Hu, and A. Severin 4-Alkyl and 4,4′-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis Bioorg Med Chem Lett 15 2005 2527 2531
53. A. Allali-Hassani, T.L. Campbell, A. Ho, J.W. Schertzer, and E-D. Brown Probing the active site of YjeE: a vital Escherichia coli protein of unknown function Biochem J 384 2004 577 584
54. A. Teplyakov, G. Obmolova, M. Tordova, N. Thanki, N. Bonander, and E. Eisenstein Crystal structure of the YjeE protein from Haemophilus influenzae: a putative Atpase involved in cell wall synthesis Proteins 48 2002 220 226
55. J. Wang, A. Galgoci, S. Kodali, K.B. Herath, H. Jayasuriya, and K. Dorso Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics J Biol Chem 278 2003 44424 44428
56. P. Kulanthaivel, A.J. Kreuzman, M.A. Strege, M.D. Belvo, T.A. Smitka, and M. Clemens Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I J Biol Chem 279 2004 36250 36258
57. P. Mishra, P.K. Park, and D.G. Drueckhammer Identification of yacE (coaE) as the structural gene for dephosphocoenzyme A kinase in Escherichia coli K-12 J Bacteriol 183 2001 2774 2778
58. C. Freiberg, H.P. Fischer, and N.A. Brunner Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants Antimicrob Agents Chemother 49 2005 749 759
59. J. Pohlmann, T. Lampe, M. Shimada, P.G. Nell, J. Pernerstorfer, and N. Svenstrup Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action Bioorg Med Chem Lett 15 2005 1189 1192
60. A.C. Price, C.O. Rock, and S.W. White The 1.3-Angstrom-resolution crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Streptococcus pneumoniae J Bacteriol 185 2003 4136 4143
61. A.C. Price, Y.M. Zhang, C.O. Rock, and S.W. White Structure of beta-ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis Biochemistry 40 2001 12772 12781
62. X. He, A.M. Reeve, U.R. Desai, G.E. Kellogg, and K.A. Reynolds 1,2-Dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH) Antimicrob Agents Chemother 48 2004 3093 3102
63. L.L. Ling, J. Xian, S. Ali, B. Geng, J. Fan, and D.M. Mills Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase Antimicrob Agents Chemother 48 2004 1541 1547
64. K.D.C. Corbett, A.J.H.P. Schoeffler, N.D. Thomsen, and J.M. Berger The structural basis for substrate specificity in DNA topoisomerase IV J Mol Biol 351 2005 545 561
65. A. Tanitame, Y. Oyamada, K. Ofuji, H. Terauchi, M. Kawasaki, and M. Wachi Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles Bioorg Med Chem Lett 15 2005 4299 4303
66. A. Tanitame, Y. Oyamada, K. Ofuji, M. Fujimoto, K. Suzuki, and T. Ueda Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring Bioorg Med Chem 12 2004 5515 5524
67. A. Tanitame, Y. Oyamada, K. Ofuji, M. Fujimoto, N. Iwai, and Y. Hiyama Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives J Med Chem 47 2004 3693 3696
68. A. Tanitame, Y. Oyamada, K. Ofuji, K. Suzuki, H. Ito, and M. Kawasaki Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity Bioorg Med Chem Lett 14 2004 2863 2866
69. A. Tanitame, Y. Oyamada, K. Ofuji, Y. Kyoya, K. Suzuki, and H. Ito Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity Bioorg Med Chem Lett 14 2004 2857 2862
70. D.G. Vassylyev, S. Sekine, O. Laptenko, J. Lee, M.N. Vassylyeva, and S. Borukhov Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution Nature 417 2002 712 719
71. R. Mariani, G. Granata, S.I. Maffioli, S. Serina, C. Brunati, and M. Sosio Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: chemical derivatization Bioorg Med Chem Lett 15 2005 3748 3752
72. M.J. Theisen, I. Misra, D. Saadat, N. Campobasso, H.M. Miziorko, and D.H. Harrison 3-Hydroxy-3-methylglutaryl-CoA synthase intermediate complex observed in "real-time" Proc Natl Acad Sci USA 101 2004 16442 16447
73. C.J. Bent, N.W. Isaacs, T.J. Mitchell, and A. Riboldi-Tunnicliffe Crystal structure of the response regulator 02 receiver domain, the essential YycF two-component system of Streptococcus pneumoniae in both complexed and native states J Bacteriol 186 2004 2872 2879
74. D. Beyer, H.P. Kroll, R. Endermann, G. Schiffer, S. Siegel, and M. Bauser New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity Antimicrob Agents Chemother 48 2004 525 532
75. R.L. Jarvest, S.G. Erskine, A.K. Forrest, A.P. Fosberry, M.J. Hibbs, and J.J. Jones Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase Bioorg Med Chem Lett 15 2005 2305 2309
76. M. Tandon, D.L. Coffen, P. Gallant, D. Keith, and M.A. Ashwell Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffold Bioorg Med Chem Lett 14 2004 1909 1911
77. K.J. Smith, C.M. Petit, K. Aubart, M. Smyth, E. McManus, and J. Jones Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species Protein Sci 12 2003 349 360
78. X. Hu, K.T. Nguyen, V.C. Jiang, D. Lofland, H.E. Moser, and D. Pei Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size J Med Chem 47 2004 4941 4949
79. X. Hu, K.T. Nguyen, C.L. Verlinde, W.G. Hol, and D. Pei Structure-based design of a macrocyclic inhibitor for peptide deformylase J Med Chem 46 2003 3771 3774